Performance of a Novel Plasma-Based Next-Generation Sequencing Assay in Patients With Bacteremia
Author(s) -
David K. Hong,
Mickey Kertesz,
Tim Blauwkamp,
Cynthia Truong,
Niaz Banaei
Publication year - 2016
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofw172.36
Subject(s) - medicine , bacteremia , dna sequencing , computational biology , oncology , intensive care medicine , bioinformatics , microbiology and biotechnology , genetics , gene , antibiotics , biology
Other: Lactobacillus paracasei, Citrobacter freundii, Morganella morgani, Streptococcus pyogenes, Salmonella enterica, Serratia marcescens, Rothia mucilaginosa 7 Background: Blood cultures are routinely obtained during the diagnostic evaluation for a number of infectious conditions such as sepsis, febrile neutropenia, and pneumonia. Despite its ubiquitous use, blood cultures have poor sensitivity due to a number of factors including previous antibiotic therapy or the presence of poorly-growing fastidious organisms. There is a need for more comprehensive diagnostic tests that can overcome these limitations to aid in guiding therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom